Association of a coding polymorphism in Fc gamma receptor 2A and graft survival in re-transplant candidates

Human Immunology

Volumn 76, Issue 10, 2015, Pages 759-764

  Arnold, Marie Luise ^a   Fuernrohr, Barbara G ^a,b   Weiß, Katrin M ^a   Harre, Ulrike ^a   Wiesener, Michael S ^a   Spriewald, Bernd M ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Anti HLA antibodies; Fc gamma receptor 2A; Graft survival; Human leukocyte antigen; Renal transplantation

Indexed keywords

FC RECEPTOR IIA; GENOMIC DNA; HLA ANTIBODY; ALLOANTIBODY; FC RECEPTOR; FCGR2A PROTEIN, HUMAN; HLA ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIALYSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETRANSPLANTATION; ALLELE; BIOSYNTHESIS; CASE CONTROL STUDY; CHILD; GENE EXPRESSION; GENETICS; GRAFT REJECTION; HETEROZYGOTE; HOMOZYGOTE; IMMUNOLOGY; KIDNEY; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; RENAL REPLACEMENT THERAPY; RISK FACTOR; SURGERY; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GRAFT REJECTION; GRAFT SURVIVAL; HETEROZYGOTE; HLA ANTIGENS; HOMOZYGOTE; HUMANS; ISOANTIBODIES; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, IGG; RENAL DIALYSIS; RISK FACTORS;

EID: 84945575254     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2015.09.034     Document Type: Article

References (32)

1. Terasaki P.I. Humoral theory of transplantation. Am. J. Transplant. 2003, 3:665-673.
2. El-Awar N., Terasaki P., Lazda V., Nikaein A., Manning C., Arnold A.N. Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies. Transplant. Proc. 2002, 34:2531-2532.
3. Harmer A.W., Koffman C.G., Heads A.J., Vaughan R.W. Sensitization to HLA antigens occurs in 95% of primary renal transplant rejections. Transplant. Proc. 1995, 27:666-667.
4. Lee P.C., Terasaki P.I., Takemoto S.K., Lee P.H., Hung C.J., Chen Y.L., Tsai A., Lei H.Y. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002, 74:1192-1194.
5. McKenna R.M., Takemoto S.K., Terasaki P.I. Anti-HLA antibodies after solid organ transplantation. Transplantation 2000, 69:319-326.
6. Worthington J.E., Martin S., Al-Husseini D.M., Dyer P.A., Johnson R.W. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003, 75:1034-1040.
7. Susal C., Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation 2002, 73:1269-1273.
8. Warmerdam P.A., van de Winkel J.G., Vlug A., Westerdaal N.A., Capel P.J. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J. Immunol. 1991, 147:1338-1343.
9. Pawlik A., Florczak M., Bak L., Dabrowska-Zamojcin E., Rozanski J., Domanski L., Gawronska-Szklarz B. The FcgammaRIIa polymorphism in patients with chronic kidney graft rejection. Transplant. Proc. 2004, 36:1311-1313.
10. Pawlik A., Florczak M., Bak L., Domanski L., Rozanski J., Dabrowska-Zamojcin E., Machalinski B., Gawronska-Szklarz B. The Fc gamma RIIa polymorphism in patients with acute kidney graft rejection. Ann. Transplant. 2003, 8:24-26.
11. Yuan F.F., Watson N., Sullivan J.S., Biffin S., Moses J., Geczy A.F., Chapman J.R. Association of Fc gamma receptor IIA polymorphisms with acute renal-allograft rejection. Transplantation 2004, 78:766-769.
12. Magnusson V., Johanneson B., Lima G., Odeberg J., Alarcon-Segovia D., Alarcon-Riquelme M.E. Both risk alleles for FcgammaRIIA and FcgammaRIIIA are susceptibility factors for SLE: a unifying hypothesis. Genes Immun. 2004, 5:130-137.
13. Manger K., Repp R., Spriewald B.M., Rascu A., Geiger A., Wassmuth R., Westerdaal N.A., Wentz B., Manger B., Kalden J.R., van de Winkel J.G. Fcgamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms. Arthritis Rheum. 1998, 41:1181-1189.
14. Raaz-Schrauder D., Ekici A.B., Munoz L.E., Klinghammer L., Voll R.E., Leusen J.H., van de Winkel J.G., Reis A., Schett G., Garlichs C.D., Hermann M. Patients with unstable angina pectoris show an increased frequency of the Fc gamma RIIa R131 allele. Autoimmunity 2012, 45:556-564.
15. Cooke G.S., Aucan C., Walley A.J., Segal S., Greenwood B.M., Kwiatkowski D.P., Hill A.V. Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa. Am. J. Trop. Med. Hyg. 2003, 69:565-568.
16. Ouma C., Keller C.C., Opondo D.A., Were T., Otieno R.O., Otieno M.F., Orago A.S., Ong'Echa J.M., Vulule J.M., Ferrell R.E., Perkins D.J. Association of FCgamma receptor IIA (CD32) polymorphism with malarial anemia and high-density parasitemia in infants and young children. Am. J. Trop. Med. Hyg. 2006, 74:573-577.
17. Brouwer K.C., Lal R.B., Mirel L.B., Yang C., van Eijk A.M., Ayisi J., Otieno J., Nahlen B.L., Steketee R., Lal A.A., Shi Y.P. Polymorphism of Fc receptor IIa for IgG in infants is associated with susceptibility to perinatal HIV-1 infection. AIDS 2004, 18:1187-1194.
18. Ozkayin N., Mir S., Afig B. The role of fcgamma receptor gene polymorphism in pediatric renal transplant rejections. Transplant. Proc. 2008, 40:3367-3374.
19. Otten H.G., Verhaar M.C., Borst H.P., Hene R.J., van Zuilen A.D. Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure. Am. J. Transplant. 2012, 12:1618-1623.
20. Susal C., Dohler B., Opelz G. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report. Hum. Immunol. 2009, 70:569-573.
21. Smith R.N., Colvin R.B. Chronic alloantibody mediated rejection. Semin. Immunol. 2012, 24:115-121.
22. Hidalgo L.G., Sis B., Sellares J., Campbell P.M., Mengel M., Einecke G., Chang J., Halloran P.F. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am. J. Transplant. 2010, 10:1812-1822.
23. Arnold M.L., Dechant M., Doxiadis I.I., Spriewald B.M. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates. Tissue Antigens 2008, 72:60-66.
24. Arnold M.L., Zacher T., Dechant M., Kalden J.R., Doxiadis I.I., Spriewald B.M. Detection and specification of noncomplement binding anti-HLA alloantibodies. Hum. Immunol. 2004, 65:1288-1296.
25. Clark M.R., Clarkson S.B., Ory P.A., Stollman N., Goldstein I.M. Molecular basis for a polymorphism involving Fc receptor II on human monocytes. J. Immunol. 1989, 143:1731-1734.
26. Salmon J.E., Edberg J.C., Kimberly R.P. Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J. Clin. Invest. 1990, 85:1287-1295.
27. Sanders L.A., Feldman R.G., Voorhorst-Ogink M.M., de Haas M., Rijkers G.T., Capel P.J., Zegers B.J., van de Winkel J.G. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect. Immun. 1995, 63:73-81.
28. Bruhns P., Iannascoli B., England P., Mancardi D.A., Fernandez N., Jorieux S., Daeron M. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 2009, 113:3716-3725.
29. Rascu A., Repp R., Westerdaal N.A., Kalden J.R., van de Winkel J.G. Clinical relevance of Fc gamma receptor polymorphisms. Ann. N. Y. Acad. Sci. 1997, 815:282-295.
30. van de Winkel J.G., Capel P.J. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol. Today 1993, 14:215-221.
31. Clark M.R., Stuart S.G., Kimberly R.P., Ory P.A., Goldstein I.M. A single amino acid distinguishes the high-responder from the low-responder form of Fc receptor II on human monocytes. Eur. J. Immunol. 1991, 21:1911-1916.
32. Boruchov A.M., Heller G., Veri M.C., Bonvini E., Ravetch J.V., Young J.W. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J. Clin. Invest. 2005, 115:2914-2923.